Taevas
United StatesFood & Dietary Supplements
Product Registration
Product Registration for Food & Dietary Supplements in United States
The United States is the world's largest dietary supplements market, but FDA compliance demands precision — from facility registration to labeling and substantiation. Taevas Global gives Food & Dietary Supplements manufacturers a clear, compliant path to
Market
United States
Industry
Food & Dietary Supplements
Service
Product Registration
Regulator
FDA Center for Food Safety and Applied Nutrition (CFSAN)
Timeline
4–8 weeks (facility registration to market-ready dossier)
What We Deliver
Six Pillars of United States Food & Dietary Supplements Intelligence
Our six interconnected pillars cover every dimension of FDA compliance and market readiness so your product registration is complete, defensible, and strategically positioned from day one.
01
Regulatory Classification and Framework
We determine whether your product is regulated as a conventional food, dietary supplement, or a new dietary ingredient under DSHEA 1994 and FDA 21 CFR Part 111. Correct classification drives every downstream compliance decision. Misclassification is one of the most common and costly errors foreign manufacturers make when entering the US market.
DSHEA vs. conventional food classification analysis
New Dietary Ingredient (NDI) notification assessment
Structure/function vs. disease claim review
How It Works
From Brief to Board-Ready Intelligence
Our four-stage engagement takes you from initial product brief to a fully documented, FDA-ready registration dossier and market entry plan in as little as six weeks.
Step 1 · Day 1–2
Discovery and Product Assessment
We begin with a structured intake call to understand your product formulation, intended claims, manufacturing location, and target US channels. Our team reviews existing documentation — including ingredient specifications, COAs, and any existing labels — to establish a baseline compliance profile. This discovery phase sets the scope and timeline for the full engagement.
Taevas Approach
Deliverables from this phase include a Product Intake Summary, a preliminary regulatory classification memo, and a prioritized list of compliance gaps to be addressed in subsequent phases. We also confirm whether an NDI notification or GRAS determination may be required for any novel ingredients.
Market Snapshot
United States Food & Dietary Supplements Market at a Glance
$0B
US Dietary Supplements Market Size (2023)
0%
Projected Annual Market Growth Rate
0K+
Registered Food & Supplement Facilities
0K+
Dietary Supplement Products on Market
FDA Oversight Is Intensifying
The FDA Center for Food Safety and Applied Nutrition has significantly increased enforcement activity, issuing over 100 dietary supplement warning letters in recent years targeting false claims, undeclared ingredients, and cGMP violations. Foreign manufacturers face heightened scrutiny at US ports of entry, with import alerts increasingly issued for facilities lacking adequate documentation. Proactive registration and compliance are no longer optional — they are the price of market access.
FSMA Is Reshaping Supply Chains
The Food Safety Modernization Act has fundamentally shifted FDA's posture from reactive to preventive, requiring manufacturers and importers to implement Hazard Analysis and Risk-Based Preventive Controls (HARPC). Foreign Supplier Verification Program (FSVP) obligations now require US importers to verify that foreign suppliers meet FDA food safety standards. Companies without robust FSMA-compliant documentation face import refusals and significant commercial disruption.
Consumer Demand Is Driving Category Expansion
Post-pandemic health awareness has accelerated demand across immune support, gut health, sports nutrition, and personalized wellness categories, creating significant white space for new entrants. E-commerce now accounts for over 30% of US dietary supplement sales, with Amazon and direct-to-consumer channels lowering the barrier to entry for foreign brands. However, platform-specific compliance requirements — including third-party testing certifications — add another layer of documentation that must be prepared in advance.
NDI Notifications Are a Growing Risk Area
The FDA has clarified that any dietary ingredient not marketed in the US before October 15, 1994 requires a New Dietary Ingredient notification at least 75 days before marketing. With the global proliferation of novel botanical extracts, fermented ingredients, and bioactive compounds, many foreign manufacturers unknowingly market products containing NDIs without proper notification. FDA has signaled it will increase enforcement in this area, making NDI screening a critical first step for any new product launch.
What's Included
Everything in Your Report
Every Taevas Global Product Registration engagement for the US Food & Dietary Supplements market delivers a complete, audit-ready documentation package covering regulatory, labeling, manufacturing, and market entry dimensions.
Regulatory Classification Memo
A definitive written determination of your product's regulatory category under FDA rules, including DSHEA applicability, NDI status assessment, and any GRAS considerations for novel ingredients.
FDA Facility Registration Documentation
Complete FDA Food Facility Registration submission package including all portal filings, US Agent appointment documentation for foreign manufacturers, and confirmed FDA registration numbers.
Label Compliance Audit Report
A line-by-line review of your product label against 21 CFR Part 101 and Part 111 requirements, with annotated redlines, mandatory corrections, and a final compliance sign-off checklist.
Claims Substantiation Dossier
A compiled evidence package supporting all structure/function claims, including relevant scientific literature summaries, a 30-day FDA notification draft, and FTC advertising alignment guidance.
cGMP Gap Analysis and Remediation Plan
A benchmarking assessment of your manufacturing practices against 21 CFR Part 111 cGMP requirements, with a prioritized remediation roadmap and SOP template library for key documentation gaps.
US Market Entry Playbook
A strategic guide to US distribution channels — including Amazon, specialty retail, DTC, and foodservice — with competitive positioning analysis, pricing benchmarks, and consumer trend insights for your category.
Post-Market Compliance Calendar
A 12-month forward-looking compliance calendar covering FDA facility registration renewals, mandatory adverse event reporting obligations, label review triggers, and key FDA guidance publication monitoring.
Regulatory Intelligence Briefing
A live briefing session with your team delivering a full walkthrough of all dossier components, inspection preparedness guidance, and a Q&A session with our US regulatory specialists.
Who This Is For
Built for These Situations
Market Entry
Foreign Manufacturer Entering the US for the First Time
You have a proven product in your home market and are ready to expand into the United States, but FDA's complex regulatory framework — facility registration, FSMA, cGMP, and labeling requirements — feels overwhelming without local expertise. You need a trusted partner who knows exactly what FDA requires, can manage submissions on your behalf, and will prevent costly mistakes before your first shipment crosses the border.
Outcome
A complete FDA-ready registration dossier, confirmed facility registration number, and a clear US market entry roadmap delivered within six weeks.
Next Steps
After Product Registration, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your United States Opportunity?
Whether you are entering the US market for the first time or resolving a compliance gap that is blocking your growth, Taevas Global's regulatory specialists are ready to build your complete FDA registration dossier and market entry strategy. Request a proposal today and speak with a US Food & Dietary Supplements expert within 48 hours.
Complete FDA-ready registration dossier delivered in 4–8 weeks
Expert guidance on DSHEA, FSMA, cGMP, and NDI requirements
Label compliance audit and claims substantiation included
Ongoing compliance retainer available for continuous US market protection